(Box) Status™ COVID-19/Flu A&B Combo Rapid Test Kit CLIA Waived, 25/Bx

SKU: BB-CF01

A Rapid Immunoassay for the Simultaneous Direct Detection and Differential Diagnosis of SARS-CoV-2, Influenza Type A and Type B Antigen from anterior nasal and nasopharyngeal swab specimens

Features and benefits

COVID-19
– Anterior nasal swab specimen − Sensitivity 93.8 %, Specificity 100%
– Nasopharyngeal − Sensitivity 93.1 %, Specificity 100%
Flu A – Sensitivity 91.4%, Specificity 95.7%
Flu B – Sensitivity 87.6%, Specificity 95.9%
FDA Emergency Use Authorization (EUA)
Visually read in 15 minutes
Flocked nasopharyngeal swab for superior specimen collection and patient comfort

Additional information
Brand

Status

Item

Antigen

CLIA

CLIA Waived

Registration

EUA FDA

Category?

Infectious Disease

Certifications

ISO 13485

Packaging and Shipping

Packaging details:

  • Minimum order quantity: One Box
  • Packaging Details: 25 Kit/ Box, 20 Boxes/ Case
  • Weight: 1.1 lbs
  • Dimensions: 10'' x 6'' x 4''

Shipping details:

  • Shipped from US Michigan.
  • Ships Same day if ordered before 12.00 p.m EST or next Business day.
  • Return is not accepted if the case or bag is opened, or the seal is broken.